Medanta Duke Research Institute Private Limited, a dissolved (liquidated) private limited company, was established on 29 December 2010 in New Delhi, Delhi, India. Engaging in pharma contract r&d within the pharma sector, it holds CIN: U73100DL2010PTC211892. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.20 M.
Formerly known as Duke India Research Institute Private Limited. It upholds a compliant status. Its leadership includes Aimee Lynne Turner (Director), Krishnakumar Udayakumar (Director), Sanjeev Kumar (Director). Past directors included Robert Mc Kinnon Califf, John Sargent Sundy, Michael Wayne Sledge. Its latest AGM occurred on 24 September 2019, with the balance sheet filed on 31 March 2019. It is based at E-18 Defence Colony, New Delhi, Delhi, 110024.
U73100DL2010PTC211892
211892
29 December 2010
₹0.50 M
₹0.20 M
Roc Delhi
Unlisted
Dissolved (Liquidated)
Explore comprehensive insights into Medanta Duke Research Institute Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Aimee Lynne Turner | Director | 02 Nov 2018 | Current |
| Krishnakumar Udayakumar | Director | 22 Sep 2014 | Current |
| Sanjeev Kumar | Director | 24 Sep 2019 | Current |
| Sanjay Mittal | Director | 23 Mar 2011 | Current |
| Naresh Trehan | Director | 01 Jun 2011 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 19 Feb 2015 | Past |
| Pramod Abcsdd | Director | 17 Sep 2014 | Past |
| Pramod Abcsdd | Director | 08 Sep 2017 | Past |
| Pramod Abcsdd | Director | 24 Sep 2019 | Past |
| Pramod Abcsdd | Additional Director | 24 Sep 2019 | Past |
| Pramod Abcsdd | Alternate Director | 25 Sep 2014 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Medanta Duke Research Institute Private Limited, for the financial year ended 2018, experienced Minor drop in revenue, with a 0.01% decrease. The company also saw a substantial improvement in profitability, with a 17.02% increase in profit. The company's net worth observed a substantial decline by a decrease of 17.04%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2018, Medanta Duke Research Institute had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Medanta Duke Research Institute, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Medanta Duke Research Institute, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medanta Duke Research Institute's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Medanta Duke Research Institute Private Limited last Annual general meeting of members was held on 24 Sep 2019 as per latest MCA records. was recorded as a recent event.
Progress on Sanjeev Kumar was appointed as a Director was appointed as a Director on 24 Sep 2019 & has been associated with this company since 6 years 2 months . was documented.
The activity Medanta Duke Research Institute Private Limited has filed its annual Financial statements for the year ended 31 Mar 2019 with Roc Delhi. was completed.
The activity Aimee Lynne Turner was appointed as a Director was appointed as a Director on 02 Nov 2018 & has been associated with this company since 7 years 26 days . was completed.
Krishnakumar Udayakumar was appointed as a Director was appointed as a Director on 22 Sep 2014 & has been associated with this company since 11 years 2 months . was recorded as a recent event.
Progress on Naresh Trehan was appointed as a Director was appointed as a Director on 01 Jun 2011 & has been associated with this company since 14 years 5 months . was documented.
DLF will be a strategic investor and Medanta will run the hospital and have operational control Global Health, India's leading private multi-speciality tertiary care provider and DLF Group (DLF), Ind.
The Average Revenue Per Occupied Bed (ARPOB), a pivotal metric for measuring growth, demonstrated a 7.1 per cent year-on-year growth, reaching Rs 63,148.
The CIN of Medanta Duke Research Institute Private Limited is U73100DL2010PTC211892.
Medanta Duke Research Institute Private Limited is headquartered at E-18 Defence Colony, New Delhi, Delhi, 110024.
Medanta Duke Research Institute Private Limited was incorporated on 29 December 2010.
The current directors of Medanta Duke Research Institute Private Limited are
The primary industry of Medanta Duke Research Institute Private Limited is Pharma.
Medanta Duke Research Institute Private Limited is unlisted.
The authorized capital of Medanta Duke Research Institute Private Limited is ₹0.50 M, and the paid-up capital is ₹0.20 M.
The compliance status of Medanta Duke Research Institute Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX